vMIP (Guangzhou Hongrun Biotech)

重组病毒巨噬细胞炎性蛋白（广州弘润生物）

Report date: 2025/07/17 17:54:11

Base Information

Drug NamevMIP (Guangzhou Hongrun Biotech)
Drug Alias Namerecombinant viral macrophage inflammatory protein
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonistsC-C chemokine receptor type 5 antagonists
TargetsC-C chemokine receptor type 5C-X-C motif chemokine receptor 4
Therapy Area/IndicationsPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangzhou Hongrun Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGuangzhou Hongrun Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsPneumonia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A